PDE4A and fragile X syndrome: This patient will also likely benefit from a targeted treatment of FXS including cannabidiol transdermal patch (CBD) [56], zatolmilast—a phosphodiesterase type 4 inhibitor (PDE4) [57], or metformin [58, 59] since other patients with FXS have done well with these medications.